home / stock / sttk / sttk quote
Last: | $11.10 |
---|---|
Change Percent: | -1.84% |
Open: | $11.06 |
Close: | $11.10 |
High: | $11.49 |
Low: | $10.7 |
Volume: | 250,934 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$11.1 | $11.06 | $11.1 | $11.49 | $10.7 | 250,934 | 05-02-2024 |
$10.86 | $10.46 | $10.86 | $11.27 | $10.24 | 202,349 | 05-01-2024 |
$10.48 | $10.79 | $10.48 | $11.28 | $10.45 | 201,469 | 04-30-2024 |
$10.97 | $10.77 | $10.97 | $11.58 | $10.77 | 647,304 | 04-29-2024 |
$10.59 | $9.82 | $10.59 | $10.64 | $9.74 | 381,467 | 04-26-2024 |
$9.78 | $9.63 | $9.78 | $9.89 | $9.4658 | 112,347 | 04-25-2024 |
$9.9 | $9.41 | $9.9 | $10.0791 | $9.41 | 234,436 | 04-24-2024 |
$9.49 | $9.3 | $9.49 | $9.78 | $9.22 | 318,756 | 04-23-2024 |
$9.3 | $9.65 | $9.3 | $9.8 | $9.23 | 307,188 | 04-22-2024 |
$9.58 | $9.97 | $9.58 | $10.28 | $9.5 | 417,167 | 04-19-2024 |
$10.13 | $10 | $10.13 | $10.31 | $9.79 | 431,040 | 04-18-2024 |
$10.02 | $9.13 | $10.02 | $10.1 | $9.13 | 555,958 | 04-17-2024 |
$8.98 | $8.97 | $8.98 | $9.175 | $8.8 | 243,080 | 04-16-2024 |
$9.09 | $9.41 | $9.09 | $9.46 | $8.99 | 107,769 | 04-15-2024 |
$9.34 | $9.67 | $9.34 | $9.9399 | $9.1642 | 158,572 | 04-12-2024 |
$9.61 | $9.82 | $9.61 | $10.25 | $9.44 | 282,058 | 04-11-2024 |
$9.76 | $8.9 | $9.76 | $9.77 | $8.89 | 621,767 | 04-10-2024 |
$9 | $8.86 | $9 | $9.185 | $8.71 | 204,029 | 04-09-2024 |
$8.79 | $9.29 | $8.79 | $9.35 | $8.79 | 112,653 | 04-08-2024 |
$9.31 | $9.11 | $9.31 | $9.5 | $9.1 | 92,811 | 04-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Shattuck Labs Inc. Company Name:
STTK Stock Symbol:
NASDAQ Market:
- Completed additional enrollment in Phase 1B dose-expansion cohorts for TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) patients in the first quarter of 2024; updated combination data expected at the European Society of Hematology (EHA) 2024 Annual Meeting in June – - Randomized,...
2024-04-16 19:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade (ICB) acquired resistance; inhibition of TRIM7 with small m...